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Abstract
Objective: We have previously described placental oxy-
genation capacity as an index of placental function. The
aim of this study was to utilize this test to evaluate pla-
cental gas exchange capacity in pre-eclampsia and fetal
growth restriction (FGR).
Study design: Two nested case-control studies were
conducted between: (i) pre-eclamptic appropriate-for-
gestational-age fetus (AGA) and non-pre-eclamptic AGA;
and (ii) pre-eclamptic FGR and non-pre-eclamptic FGR
based on gestational age match. Umbilical A-V gas dif-
ferences were compared between groups.
Results: Pre-eclamptic AGA was associated with smaller
A-V pO2 and A-V pCO2 differences compared to non-pre-
eclampsia (A-V pO2, 7.1"3.8 mm Hg vs. 11.3"5.9 mm
Hg, Ps0.001; A-V pCO2, 7.8"5.7 mm Hg vs. 10.7"
5.9 mm Hg, Ps0.01). Pre-eclamptic FGR was associated
with smaller A-V pO2 and A-V pCO2 differences com-
pared to non-pre-eclampsia (A-V pO2, 6.6"3.1 mm Hg
vs. 10.8"8.1 mm Hg, P-0.001; 6.7"4.5 mm Hg vs.
10.9"10.3 mm Hg, Ps0.044). Pre-eclamptic FGR also
had significantly lower venous pO2 but not arterial pO2
(Venous pO2, 20.3"6.3 mm Hg vs. 25.4"11.9 mm Hg,
Ps0.003).
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Conclusion: Pre-eclampsia decreases the placental oxy-
genation capacity as measured by the umbilical arterial-
venous oxygen difference.
Keywords: Intrauterine growth restriction; oxygenation;
placenta; pre-eclampsia; umbilical cord blood gas.
Introduction
The placenta is the nutrient and gas exchange organ
between mother and fetus. The adequacy of gas ex-
change is related to maternal placental perfusion and
the adequacy of uptake is related to fetal perfusion and
ramification of the villous tissue. We have previously
described an index of placental function in terms of
placental oxygenation capacity (umblical arterial-venous
oxygen difference, or A-V pO2 difference) w9x. In the
study, the placenta had constant oxygenation through-
out pregnancy, independent from gestational age, birth
weight, duration of labor, and mode of delivery.
Since pre-eclampsia is frequently associated with
shallow placentation caused by inadequate trophoblast
invasion into the maternal spiral artery w4, 6, 7, 13x, it
might be a model for abnormalities in the maternal com-
partment. Fetal growth restriction (FGR) on the other
hand is frequently associated with umbilical blood flow
abnormalities and decreased oxygen availability w12x,
and therefore, serves as a model of abnormalities in the
fetal compartment.
The aim of the study is to evaluate the impacts of
maternal, fetal, and placental dysfunction on placental
oxygenation capacity.
Patients and methods
Nested case-control studies were conducted using arterial and
venous umbilical cord blood data recorded as part of a multi-
center observational study of growth restricted fetuses. An addi-
tional set of patients was ascertained from our prospectively
maintained perinatal database. Only singleton pregnancies deliv-
ered by pre-labor cesarean delivery were included. Excluded
were also patients with fetal anomalies, placental abruption,
umbilical cord prolapse, uterine rupture, and bleeding placenta
previa.
The abstracted data included presence or absence of pre-
eclampsia, gestational age at delivery, mode of delivery, indi-
cation of delivery, anesthesia at delivery, Apgar scores, infant
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Table 1 Umbilical cord gasses analyses in appropriate-for-gestational-age fetus.
Subjects Pre-eclampsia Non-pre-eclampsia P-value
ns33 ns66
Gestational age (weeks) 30.4"3.6 30.4"3.6 1.0
Birth weight (g) 1518"648 1685"811 0.4
Apgar 1 min 6 (1–9) 6 (1–9) 0.68
Apgar 5 min 8 (2–9) 8 (2–9) 0.77
Arterial pH 7.20"0.12 7.22"0.1 0.49
Arterial pO2 13.9"6.7 15.3"6.5 0.29
Arterial pCO2 60.3"16.7 59.8"13.6 0.68
Arterial HCO3 22.4"3.8 23.5"3.9 0.08
Arterial base excess –6.0"4.8 –4.8"4.4 0.11
Venous pH 7.24"0.12 7.29"0.09 0.03
Venous pO2 21.0"5.9 26.6"8.1 0.001
Venous pCO2 52.5"15.1 49.1"12.6 0.29
Venous HCO3 22.1"4.1 23.0"2.5 0.26
Venous base excess –5.0"5.2 –3.4"3.2 0.06
A-V pO2 difference 7.1"3.8 11.3"5.9 0.001
A-V pCO2 difference 7.8"5.7 10.7"5.9 0.01
Mean"SD or median (range) is shown. Mann-Whitney U-test for all statistic comparisons.
Figure 1 A-V pO2 difference in appropriate-for-gestational-age
fetus. Blackspre-eclampsia, Graysnon-pre-eclampsia.
weight with birth weight percentile, and the results of umbilical
cord arterial and venous blood gasses. Umbilical cord blood
gasses include pH, pO2, pCO2, , and base excess. The
–HCO3
crude A-V pO2 and pCO2 differences were calculated and were
expressed as absolute values w9x. Pre-eclampsia was defined as
a sustained blood pressure G140/90 mm Hg with proteinuria
G300 mg from a 24-h urine collection or G1q, after 20 weeks
of gestation w16x. FGR was defined as the birth weight below
the 10th percentile of gestational age in association with abnor-
mal umbilical artery Doppler index w1x.
Two nested studies were conducted between: (i) pre-eclamptic
patients with an appropriate-for-gestational-age fetus (AGA)
and non-pre-eclamptic AGA; and (ii) pre-eclamptic FGR and
non-pre-eclamptic FGR. Patients were matched by gestational
age at delivery.
Continuous variables were analyzed by Mann-Whitney U-test
and mean"SD or median with interquartile range, as appropri-
ate. Pearson’s correlation analysis and regression analysis with
95% individual prediction interval were used as appropriate.
Two-tailed tests with P-0.05 were considered significant. The
statistical significance was determined using Statistical Package
for Social Scientists software (SPSS, Inc., version 12.0, Chicago,
IL). The study protocol was approved by the Institutional Review
Board (IRB) at the University of Maryland School of Medicine.
Results
Three hundred and seventy-nine patients were evaluated:
138 (36.4%) of non-pre-eclamptic AGA, 114 (30.1%) of
pre-eclamptic FGR, 80 (21.1%) of non-pre-eclamptic
FGR, and 47 (12.4%) of pre-eclamptic AGA. Due to these
proportions, one-to-two ratio gestational age based
match was performed between pre-eclamptic AGA and
non-pre-eclamptic AGA (post-hoc analysis).
Pre-eclampsia vs. non-pre-eclampsia in AGA
Patient characteristics and umbilical cord gas analyses
are shown in Table 1. Mean gestational age in both
groups was 30.4"3.6 weeks. The proportions of type of
anesthesia were similar in the two groups (general anes-
thesia, pre-eclampsia vs. non-pre-eclampsia, 45.2% vs.
28.6%, Ps0.16). Umbilical arterial pO2 in pre-eclampsia
was similar to non-pre-eclamptics (13.9"6.7 mm Hg vs.
15.3"6.5 mm Hg, Ps0.29) whereas significantly smaller
venous pO2 return was seen in pre-eclampsia compared
to non-pre-eclampsia (21.0"5.9 mm Hg vs. 26.6"8.1
mm Hg, Ps0.001). Accordingly, oxygenation capacity in
pre-eclamptic placenta, the A-V pO2 difference, was sig-
nificantly smaller than in the non-pre-eclamptic placenta:
7.1"3.8 mm Hg vs. 11.3"5.9 mm Hg, Ps0.001. Pla-
cental oxygen supply was constant during pregnancy
(Figure 1). Pre-eclamptic patients showed smaller distri-
bution of oxygenation compared to non-pre-eclampsia.
Pre-eclamptic patients also had smaller carbon dioxide
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Table 2 Umbilical cord gasses analyses in intrauterine growth restriction fetus.
Subjects Pre-eclampsia Non-pre-eclampsia P-value
ns67 ns67
Gestational age (weeks) 30.2"3.0 30.2"3.0 1.0
Birth weight (g) 989"360 964"406 0.44
Apgar 1 min 5 (1–9) 6 (1–9) 0.73
Apgar 5 min 8 (2–9) 8 (2–9) 0.82
Arterial pH 7.23"0.09 7.20"0.10 0.12
Arterial pO2 13.7"5.4 14.5"7.9 0.97
Arterial pCO2 57.8"10.6 60.1"11.7 0.25
Arterial HCO3 23.3"3.5 22.1"3.8 0.044
Arterial base excess –6.3"4.8 –4.6"4.6 0.039
Venous pH 7.27"0.09 7.26"0.09 0.49
Venous pO2 20.3"6.3 25.4"11.9 0.003
Venous pCO2 51.2"9.8 49.2"11.9 0.36
Venous HCO3 22.9"3.6 22.3"3.0 0.23
Venous base excess –4.7"4.1 –3.8"4.2 0.27
A-V pO2 difference 6.6"3.1 11.4"8.0 -0.001
A-V pCO2 difference 6.7"4.5 10.9"10.3 0.044
Mean"SD or median (range) is shown. Mann-Whitney U-test for all statistic comparisons.
Figure 2 A-V pCO2 difference in appropriate-for-gestational-
age fetus. Blackspre-eclampsia, Graysnon-pre-eclampsia.
Figure 3 A-V pO2 difference in fetuses with growth restriction.
Blackspre-eclampsia, Graysnon-pre-eclampsia.
clearance: A-V pCO2 difference, 7.8"5.7 mm Hg vs.
10.7"5.9 mm Hg, Ps0.01 (Table 1). Throughout preg-
nancy, A-V pCO2 difference in pre-eclampsia was smaller
(Figure 2).
Pre-eclampsia vs. non-pre-eclampsia in FGR
Placental oxygenation capacity was evaluated between
pre-eclamptic FGR and non-pre-eclamptic FGR (Table 2).
Mean gestational age in the two groups was 30.2"3.0
weeks. The proportions of type of anesthesia were similar
in the two groups (general anesthesia, pre-eclampsia vs.
non-pre-eclampsia, 34.5% vs. 42.6%, Ps0.42). Placen-
tal oxygenation capacity in pre-eclamptic FGR was sig-
nificantly decreased compared to non-pre-eclamptic
FGR (6.6"3.1 mm Hg vs. 11.4"8.0 mm Hg, P-0.001).
This was supported by significantly smaller oxygenated
venous return seen in pre-eclampsia whereas similar
arterial oxygen tension were seen in both groups: venous
pO2, 20.3"6.3 mm Hg vs. 25.4"11.9 mm Hg, Ps0.003;
arterial pO2, 13.7"5.4 mm Hg vs. 14.5"7.9 mm Hg,
Ps0.97. The A-V pCO2 difference in pre-eclamptic
FGR was smaller than in non-pre-eclamptic women
(6.7"4.5 mm Hg vs. 10.9"10.3 mm Hg, Ps0.044).
Placental oxygen supply in FGR was constant during
pregnancy (Figure 3). Pre-eclamptic FGR pregnancies
showed smaller distribution of oxygenation compared to
non-pre-eclamptics.
A-V pO2 difference between pre-eclampsia with AGA
fetus and pre-eclampsia with FGR fetus appears similar
(Figure 4).
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Figure 4 Pre-eclampsia and arteriovenous pO2 and pCO2 difference. Pre-eclampsia decreases placental gas exchange capacity.
PIHspre-eclampsia; AGAsappropriate-for-gestational-age; IUGRsintrauterine growth retardation. *Ps0.001 (compared to non-PIH
AGA), **P-0.001 (compared to non-PIH FGR), qPs0.01 (compared to non-PIH AGA), qqPs0.044 (compared to non-PIH FGR).
Discussion
Umbilical arterial-venous gas difference was recently
described to evaluate the placental respiratory function
w9x. Placental oxygenation capacity remained steady
through pregnancy w9x. This new approach of placental
respiratory function was applied in this study to evaluate
the effects of placental dysfunction using pre-eclampsia
and FGR as models of abnormal placentation in the
maternal and fetal compartments, respectively.
Our results suggest that pre-eclampsia is associated
with decreased placental gas exchange capacity irre-
spective of the fetal growth pattern. Surprisingly, similar
placental gas exchange capacity was observed between
AGA and FGR fetuses in pre-eclamptic women. Several
observations require further elaboration.
Pre-eclampsia decreases placental gas exchange. This
is consistent with the shallow placentataion theory as a
pathophysiologic basis of pre-eclampsia w4, 6, 7, 13x.
With normal placentation, the cytotrophoblast invades
into the maternal spiral artery within the endometrium to
obtain higher oxygen content. With the invasion of the
trophoblast, the spiral arteries are transformed from high
resistance vessels into larger vessels with low resistance.
This vessel remodeling is completed by 18–20 weeks of
gestation w4, 13x. Trophoblast differentiation is normal
under normal arterial oxygen tension, but continues pro-
liferating under low oxygen tension w3x. Abnormal tro-
phoblast invasion of the spiral arteries, such as in pre-
eclampsia, leads to hypoxic trophoblast cells. Hypoxic
stress alters placental villous angiogenesis, which leads
to a poorly developed fetoplacental vasculature w5, 11x.
The transfer of oxygen from mother to fetus is limited
by blood-flow through the intervillous space w8x. Thus, in
pre-eclampsia, the suboptimal placental nutrition and
oxygenation predisposes to placental insufficiency and
inadequate uteroplacental perfusion w2, 14x.
Whether the decreased gas exchange is the chronic
in-utero manifestation in pre-eclampsia or is the terminal
phenomenon secondary to placental inflammation such
as neutrophil accumulation and activation needs further
investigation. Increased placental anti-angiogenic factors
far prior to the clinically evident pre-eclampsia w6x or
increased neutrophil distribution in placentation phase
of pre-eclampsia w10x may suggest that the decreased
placental gas exchange may be the long-term in utero
event seen in pre-clinical stages of pre-eclampsia.
FGR is one of the severe clinical complications of pre-
eclampsia. Decreased oxygen availability is reported as
the cause of FGR w12x. Thus, FGR with pre-eclampsia
increases the risk for decreased oxygenation capacity
compared to FGR in non-pre-eclamptics. Interestingly,
pre-eclamptic FGR pregnancies showed lower umbilical
A-V pO2 differences and lower umbilical venous oxygen
tension than non-pre-eclamptic FGR pregnancies (Table
2), without difference in umbilical arterial oxygen tension
in both groups. This implies that the placenta of pre-
eclamptic FGR pregnancies has lower oxygenation
capacity than non-pre-eclamptic FGR, and thus the
umbilical venous return supplies lower oxygen tension to
the fetus potentially contributing to the genesis of FGR.
Decreased placental oxygenation capacity is character-
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istic of the FGR in pre-eclampsia. However, to our sur-
prise, A-V pO2 difference between pre-eclampsia
with AGA fetus and pre-eclampsia with FGR fetus seems
similar (Figure 4). This is possibly explained by delivery
prior to clinical deterioration of the fetal condition or for
maternal indications irrespective of fetal status. In either
case, fetal acid-base status may not yet have been
affected. Further study into the rate of clinical progres-
sion of pre-eclamptic and non-pre-eclamptic FGR preg-
nancies is necessary to clarify these observations.
It is possible that more pre-eclamptic women were
delivered by cesarean section under general anesthesia
than non-pre-eclamptic women, where regional anesthe-
sia was more frequently used. Our results showed that
there was no statistical difference in the proportions of
type of anesthesia between pre-eclampsia and non-pre-
eclampsia in both appropriately-grown and growth
restricted fetuses. We previously investigated umbilical
arterio-venous cord blood gas difference in uncompli-
cated spontaneous vaginal and non-labor cesarean sec-
tion w9x. The values of arterio-venous gas differences
among cesarean delivery in that study are similar to our
result from non-pre-eclamptic growth restricted cases
w9x. Although our results were unaffected by the type of
anesthesia, it is generally recognized that the type
of anesthesia such as general anesthesia at the time of
delivery may interfere with the values of umbilical cord
blood gases w15x. Therefore, it is potentially explained
that our findings may be due to the short-term effect of
type of anesthesia. Our study was limited in the sample
size and further studies are needed.
The exact mechanism for the difference in placental
gas transfer differences between pre-eclamptic and nor-
mal women cannot be determined by this study. We can
postulate that diffusion distance between the intervillous
space and the fetal villous vasculature is increased, per-
haps due to increased interstitial edema. Since oxygen
is far more prone to diffusion defects, this can explain
the decreased arteriovenous oxygen difference. Alterna-
tively, pre-eclamptic women may have villous occlusive
disease in the absence of umbilical artery Doppler abnor-
malities. These could lead to placental perfusion abnor-
malities as the main cause of altered oxygen capacity. In
the absence of correlation with placental ultrastructure
evaluation these questions cannot be addressed by this
study and certainly open the possibility for further
research.
While there were enough cases to do a one-to-one
match between pre-eclamptic FGR and non-pre-eclamptic
FGR (114 vs. 80 cases, respectively), there were not
enough cases to do a one-to-one match between the
two groups of AGA (non-pre-eclamptic AGA vs. pre-
eclamptic AGA, 138 vs. 47 cases, respectively). In order
to maximize the chance to reflect the crude data values
of the cases, we decided to perform a one-to-two match
in the study.
In conclusion, umbilical arterial-venous cord blood
gas difference, a novel index of placental respiratory func-
tion, was successfully applied to pre-eclampsia, demon-
strated that pre-eclamptic FGR is significantly associated
with a decreased placental oxygenation capacity. This
useful placental respiratory function test requires further
investigation in various pathologic conditions during
pregnancy.
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